---
title: 'Physiological Pharmacokinetic Models: Applications'
author: "Richard Upton"
date: "January 28, 2015"
output:
   ioslides_presentation:
      css: assets\css\slidify.css
      widescreen: false
      smaller: false
      logo: images\unisa_logo.jpg
      mathjax: local
      self_contained: false
      keep_md: true
 
---

## Some Applications of PBPK models    


```{r setup, cache = F, echo = F, message = F, warning = F}
# make this an external chunk that can be included in any file
#options(width = 70)
#opts_chunk$set(message = F, error = F, warning = F, echo = F, comment = NA, fig.align = 'center', dpi = 100, fig.height = 4.5, fig.width = 8, tidy = F, fig.path = 'fig/', cache = FALSE, cache.path = '.cache/')
#require(ggplot2);
require(xtable)
options(xtable.type = 'html')

source("Rcode/global.R")
```
Examples from my own back catalogue:

* **Interspecies scaling**  
    Using animal data in a human model  

* **Drugs that affect blood flow**  
    Intravenous Magnesium

* **Drugs that have a "target" organ**  
    Propofol (Intravenous anaesthetic)  

* **First-pass metabolites**
    Leflunomide/Teriflunomide (RA)

* **Effect of physiological changes/pathology**  
    Predict the effect of aging on fentanyl kinetics



# Interspecies scaling



## First in Man: Animal to Human
Typically mice, rats, dogs to man  

**Compartmental models**  
Scale volumes and clearances using allometric principles  
Doesn't take into account differences in body composition  
"Blurring" of clearance & volume (distribution or absorption masked as clearance)  

**PBPK models**  
Define model as physiological and pharmacological parameters  
"Swap" the physiological parameters for a new species  
Keep the pharmacological parameters the same  
(or vice versa for predicting a new drug in the same species!)



## PBPK model parameters

**Physiological**  
Organ size/volume  
Organ blood flow  
Organ composition (e.g. lipid content)  
Organ enzyme contents  
Haematocrit/plasma protein concentrations  

**Pharmacological**  
Partition coefficient  
Free fraction  
Kb values (binding)  

Extraction ratio  
Km values (enyzmes)  
Intrinsic clearance  



##  The Standard Sheep
Example of physiological data from the literature

<center>
![stdsheep](images/standard_sheep_table.png)
</center>

<h4>
Upton, J Pharmacol Toxicol Methods 2008; 58:198-205
</h4>


##  The Standard Pig

<Center>
![stdpig](images/standard_pig_table.png)
</center>

<h4>
Upton, J Pharmacol Toxicol Methods 2008; 58:198-205
</h4>



##  Scaling body composition
    

Body composition varies with species  
<br>
**Sheep vs Pig**     
   
_Standard sheep_  
17% fat and 28% muscle  
Liver blood flow is 47% of cardiac output  
  
_Standard pig_  
30% fat and 40% muscle  
Liver blood flow is 30% of cardiac output  



##  Scaling size within a species  

Animals come in different sizes, even within a species  
  
To generate a simulated population:   
_1.  Assume % body composition is the same_  
_2.  Scale organ size relative to the standard size_  


<div style="font-size: 90%;">  
$$
    {\sf OrganSize_{i} = OrganSize_{std}* \left( \frac{Weight_{i}}{Weight_{std}} \right)^1*N\left(1,0.08^2 \right)\\  }
    {\sf OrganFlow_{i} = OrganFlow_{std}* \left( \frac{Weight_{i}}{Weight_{std}} \right)^{0.75}*N\left(1,0.15^2 \right) } \\  
$$
</div>

<h4>
Upton, J Pharmacol Toxicol Methods 2008; 58:198-205
</h4>



##  Scaling organ distribution  
  
Consider a membrane-limited model  
Measured apparent distribution volumes (V~app~), permeabilty (PS) and blood flow (Q)  
  
Animal   |    | Man  
----|-------|------  
Dimensioned | Dimensionless |  Dimensioned  
V~app,a~ (L)    | R = V~app,a~/V~real,a~ |  V~app,m~ = R.V~real,m~ (L)  
PS~a~ (L/min)   | PSQ = PS~a~/Q~a~       | PS~m~ = PSQ.Q~m~ (L/min)  



##  Scaling organ elimination  

Measured organ clearance (CL) blood flow (Q)  
<br>
  
Animal   |    | Man
----|-------|------
Dimensioned | Dimensionless |  Dimensioned  
CL~a~ (L/min)    | E = CL~a~/Q~a~ |  CL~m~ = E.Q~m~ (L/min)



##  A recirculatory model of fentanyl in man  {.flexbox .vcenter} 

![fentrecirculatory](images/fentanyl_recirculatory.png)



##  Scaling membrane limited distribution {.flexbox .vcenter}

![fentmanparameters](images/fentanyl_man_parameters.png)

<h4>
Upton et al., J Pharmacokinetic Pharmacodyn 2012; 39: 561-76 
</h4>



##  A recirculatory model of fentanyl in man  {.flexbox .vcenter} 

![fentrecirculatorytable](images/fentanyl_recirculatory_table.png)

<h4>
Upton et al., J Pharmacokinetic Pharmacodyn 2012; 39: 561-76 
</h4>



# Drugs that affect blood flow



## Intravenous Magnesium
<br>    

Used for a number of diseases, including preeclampsia  
  
Relaxes smooth muscles in blood vessels  
  
* Lowers systemic vascular resistance  
* Decreases mean arterial blood pressure  
* Increases in cardiac output  
  
Dosing is often empirical, based on observed cardiovascular variables  


##  Magnesium Pharmacokinetics
<br>
The clearance of magnesium is renal, but it can be reabsorbed or excreted in the
tubules, as dictated by homeostatic requirements  
  
Predominant loss from blood is by cellular uptake.  This occurs in all tissues, and is potentially blood flow (cardiac output) dependent  
  
<center>  
**The PK of Mg affects the PD**  
<br>
**The PD of Mg affects the PK**  
</center>  



##  A Study of Magnesium in Sheep

A chronically instrumented sheep preparation  

Training data set (30 mmol over 2 min)  

Arterial blood samples for PK  

**Cardiovascular measurements**  
LVEDP -  Left ventricular end diastolic pressure  
MAP   -  Mean arterial blood pressure  
SVR   -  Systemic vascular resistance  
CO    -  Cardiac output  
HR    -  Heart Rate  
SV    -  Stroke Volume  
CNT   -  Contractility  



##  Magnesium - Observed data {.flexbox .vcenter}
3 = baseline; 2 = baseline/2; 4 = baseline.2

![mgrawdata](images/Mg_rawdata.png)



##  Magnesium - PD model {.flexbox .vcenter}
A simple model of the cardiovascular system  
Two "stressed" blood volumes, active pump, passive return

![mgPDmodel](images/Mg_PD_model.png)

<h4>
Upton & Ludbrook, BMC Pharmacology 2005; 5:5, 10 Mar 
</h4>

##  Magnesium - PK model  {.flexbox .vcenter}
A 2 compartment recirculatory model with CO as a parameter  
Distribution into intracellular stores (PS)   

![mgPKmodel](images/Mg_PK_model.png)



##  Magnesium - PKPD model  {.flexbox .vcenter}
Feedback between the PK and PD models via link functions  

![mgPKPDmodel](images/Mg_PKPD_model.png)



##  Magnesium - Observed vs Fitted {.flexbox .vcenter}

![mgresults](images/Mg_results.png)



##  Magnesium - Validation data {.flexbox .vcenter}
Prediction of a validation data set (30 mmol over 5 min)  

![mgvalidation](images/Mg_validation.png)



# Drugs with "target" organs



## Propofol
* Intravenous anaesthetic  
* GABA agonist (and other receptors)  
* Depression of neuronal activity evident in the EEG  
* Propofol concentration in the CNS determines the time-course of anaesthesia  
 
<br>
Why not include the target organ in a model of propofol kinetics?

<br>
<h4>
Upton & Ludbrook, Anesthesiology 2005; 103:344-52  
</h4>



##  Propofol - Recirculatory Model {.flexbox .vcenter}

![propofolrecirculatory](images/propofol_recirculatory.png)  




##  Propofol - Lung Sub-model 
ICG = concurrent intra-vascular marker  

<center>
![propofollungdata](images/propofol_lung_data.png)  
</center>


##  Propofol - Lung Sub-model
Flow = Cardiac output (Q~co~)  
Input = Pulmonary artery (C~pa~); Output = Aorta (C~art~)  

<br>
<center>
![propofollungmodel](images/propofol_lung_model.png)  
</center>


##  Propofol - Brain Sub-model
Input = Aorta (C~art~); Output = Jugular bulb (C~jug~)  
BIS = Depth of anaesthesia  

<center>
![propofolbraindata](images/propofol_brain_data.png)  
</center>


##  Propofol - Brain Sub-model
Membrane limited model  
Feedback effect on cerebral blood flow  

<center>
![propofolbrainmodel](images/propofol_brain_model.png)  
</center>


## Standard Man to Population model

This was NOT a population model!  
Mean data, Standard Man physiology  
Fitting in MATLAB & Simulink  
Can you predict a population?  Maybe...

<div style="font-size: 70%;">  
$$
     {\sf CO_{i} = 5.66* \left( \frac{Weight_{i}}{70} \right)^{0.41} * \left( 1.03 + 0.0295*\left( Age/30 \right)  + 0.0603*\left( Age/30 \right)^2 \right) }  \\ 
 {\sf OrganSize_{i} = OrganSize_{std}* \left( \frac{Weight_{i}}{70} \right)^1 } \\       
$$
</div>

Now predict arterial propofol concentrations for an extensive database of real patients!  

##  The harsh reality
"Performance of compartmental and physiologically-based, recirculatory pharmacokinetic models for propofol "  
<center>
![masuipropofolpredictions](images/masui_propofol_predictions.png)
</center>

<h4>
Masui et al., Anesthesia and Analgesia 2010; 111: 368-79 
</h4>



# Oral dose first-pass metabolites



## Leflunomide/Teriflunomide 
undetectable parent, first-pass metabolism, blood-borne metabolism, extensive protein binding, entero-hepatic recycling, genetic influence on transporters & CYP's  

<center>
![ashmodel](images/Ash_leflunomide.png)

<h4>
Hopkins et al., 2015, under review  
</h4>
</center>



# Effect of physiological changes/pathology  



## Fentanyl in the elderly  

You are a pharmacologist working in an Anaesthetic Department  

**What happens to the kinetics of fentanyl in the elderly?**  
**Why do you need 1/4 of the dose of a fit young person?**  

The literature has no published model of fentanyl in the elderly  

From first principles, what happens to drug kinetics when people age?  



##  Physiology of aging {.flexbox .vcenter}

![agetable](images/ageing_table.png)  

<h4>
MacIntyre, Clinical Pain Management-Acute, Edward Arnold, 2002 pp 463.  
</h4>

##  Modify this model for the elderly! {.flexbox .vcenter}


![fent3comp](images/Fentanyl_3comp.png)  



##  Modify this model for the elderly?

<center>
![fentPBPK](images/Fentanyl_PBPK.png)  
</center>

<h4>
Bjorkman, J Pharmacokinet Biopharm. 1994; 22:381-410.   
</h4>



##  Conclusions

Investigate models beyond the 1, 2 & 3 compartment mamillary  

Make some (informed!) assumptions, or use data beyond arm venous plasma concentrations  

Old data/papers may be valuable pieces of the puzzle  

Learn software to solve differential equations  

There is more work to do.  For example, how reliable is this equation for fit, healthy adults?  

<div style="font-size: 100%;">  
$$
     {\sf LiverFlow_{i} = 1.5* \left( \frac{Weight_{i}}{70} \right)^{0.75}* \left( \frac{Age_{i}}{30} \right)^{x} } \\  
$$
</div>


#  The End  



